Oxidative stress is caused by reactive oxygen species (ROS) during cerebral ischemia, potentially leading to cell death and ultimately brain death after reperfusion. Especially during reperfusion, superoxide anion radicals, hydroxyl radicals, and nitric oxide (NO) are produced, which can cause lipid peroxidation, inflammation, and apoptosis. The cerebral vasculature is a major target of oxidative stress, which plays a key role in the pathogenesis of ischemic brain injury following cerebrovascular attacks. In addition, mitochondrial dysfunction is caused after stroke, and oxidative stress further aggravates mitochondrial damage. Actively protecting mitochondrial function, resisting oxidation, scavenging free radicals, and mitigating oxidative stress have become effective strategies to save neurons from the pathological process of cerebral ischemia-reperfusion.
Fig. 1. Therapeutic opportunities throughout the time-course of oxidative stress development in ischemic stroke. (Qin et al., 2022)
Ace Therapeutics provides molecular mechanism analysis services focused on oxidative stress in stroke, assisting clients in the development of novel pharmaceuticals. Our team of highly skilled researchers and scientists can use state-of-the-art technologies and methods to reveal the complex interactions between ROS production, antioxidant defense systems, and cell damage in stroke.
Analysis of Molecular Mechanisms of Oxidative Stress in Stroke
We can analyze the following signaling pathways associated with mitochondrial dysfunction and oxidative stress in in vitro and in vivo models of stroke.
We can help clients develop a range of biomarkers to assess levels of oxidative stress and evaluate disease progression in stroke.
Through our comprehensive analytical services, multidisciplinary approach, and state-of-the-art facilities, we strive to be your trusted partner. Contact us to move your stroke program forward!
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.